
COVID, Год журнала: 2025, Номер 5(4), С. 48 - 48
Опубликована: Март 31, 2025
The COVID-19 pandemic has led to persistent complications beyond the respiratory system, with emerging evidence highlighting role of gut dysbiosis in long COVID. Given established gut–skin axis, alterations microbiota post-COVID-19 may contribute dermatologic conditions such as eczema, acne, and rosacea. This review explores mechanisms by which SARS-CoV-2 disrupts microbiome, leading systemic inflammation skin disease. Furthermore, it examines potential interventions, including probiotics, prebiotics, dietary modifications, microbiome-targeted therapeutic strategies for post-COVID recovery. Understanding this link open new avenues treating chronic inflammatory COVID patients.
Язык: Английский